Tempest Therapeutics names Nicholas Rossettos CFO, replacing Justin Trojanowski - TPST News | RalliesTempest Therapeutics names Nicholas Rossettos CFO, replacing Justin Trojanowski
T
TPST• CFO transition
- Tempest Therapeutics’ principal financial and accounting officer Justin Trojanowski will resign effective Sept. 1, 2026.
- Nicholas Rossettos will take over as CFO, principal financial and accounting officer, treasurer, and corporate secretary effective Sept. 1.
- Rossettos previously advised TransCode Therapeutics from April 2025, served as interim CFO of Sernova from March to October 2024.
- He has provided CFO consulting services since 2012, including with Charles River CFO, following an earlier CFO role at Egenix from 2006 to 2012.
